Description |
RAP1A, member of RAS oncogene family |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
GWAS |
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Crohn's disease ( 30500874)
- High altitude adaptation ( 28373541)
- Osteoporosis-related phenotypes ( 20548944)
|
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU) ( 24025145)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757)
- Asthma (childhood onset) ( 27611488)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Lead levels ( 26025379)
- Lung function (FEV1) ( 30061609)
- Lung function (FVC) ( 30061609)
- Monobrow ( 27182965)
- Neuritic plaque ( 31497858)
- Nose size ( 27182965)
- Parkinson's disease ( 26227905)
- Superior frontal gyrus grey matter volume ( 25335168)
- Systolic blood pressure ( 26969751)
|